Background HCV prevalence in people living with HIV (PLWHIV) is approximately 25% and progression of liver disease is accelerated in PLWHIV. ECHO is a telementoring “hub and spoke” model based on knowledge-sharing networks led by expert teams using videoconferencing for sessions with community healthcare providers. We describe development and implementation of an HIV/HCV ECHO to educate/support primary care and infectious disease (ID) providers to treat HCV in PLWHIV.

Methods Development began in October 2017. The expert panel assembled consisted of: ID specialist, hepatologist, psychiatrist, addiction medicine specialist, pharmacist, community health worker. An HIV/HCV didactic curriculum was developed. Initial spoke sites were providers at five HIV clinics. Equipment set up was ensured at the hub site. Minimal hardware requirement for spoke participation was a smart phone. A project website was developed. Innovations in use of REDCap, a cloud database platform, were developed. UT Health San Antonio HIV/HCV ECHO launched 1st October 2018.

Results One-hour ECHO sessions are held twice a month. The HIV/HCV curriculum covers 11 topics. From 1st October 2018 – 22nd January 2019, 158 individuals participated in sessions including clinicians responsible for 1,155 PLWHIV, 42 co-infected with HCV. REDCap innovations included direct entry of de-identified clinical information for sessions into REDCap with export into a PDF format, automatic assignment of ECHO identification numbers for initial and follow up case presentations, direct entry of information required for Continuing Medical Education credit into REDCap. Website views were 1887 with 253 individuals using the site.

Conclusion ECHO has been an effective foundation for a growing Community of Practice and Learning for HIV/HCV management. REDCap innovations facilitate ECHO administration. Reach to HIV/HCV co-infected patients has been demonstrated. The ECHO model should be considered to improve education about HCV management among HIV providers and to improve access to HCV treatment and cure for PLWHIV in their medical home.

Disclosure No significant relationships.